hugh rickards
hugh rickards
Hon Professor in Neuropsychiatry, Birmingham University
Verified email at
Cited by
Cited by
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
V Roessner, KJ Plessen, A Rothenberger, AG Ludolph, R Rizzo, L Skov, ...
European child & adolescent psychiatry 20 (4), 173-196, 2011
European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions
C Verdellen, J Van De Griendt, A Hartmann, T Murphy, ...
European child & adolescent psychiatry 20 (4), 197-207, 2011
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
The cognitive impact of antiepileptic drugs
CM Eddy, HE Rickards, AE Cavanna
Therapeutic advances in neurological disorders 4 (6), 385-407, 2011
Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke
H Rickards
Journal of Neurology, Neurosurgery & Psychiatry 76 (suppl 1), i48-i52, 2005
Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome
M Porta, A Brambilla, AE Cavanna, D Servello, M Sassi, H Rickards, ...
Neurology 73 (17), 1375-1380, 2009
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
E van Duijn, D Craufurd, AAM Hubers, EJ Giltay, R Bonelli, H Rickards, ...
Journal of Neurology, Neurosurgery & Psychiatry 85 (12), 1411-1418, 2014
Should patients participate in clinical decision making? An optimised balance block design controlled study of goal setting in a rehabilitation unit
RC Holliday, S Cano, JA Freeman, ED Playford
Journal of Neurology, Neurosurgery & Psychiatry 78 (6), 576-580, 2007
Therapies for depression in Parkinson's disease
S Ghazi‐Noori, TH Chung, K Deane, HE Rickards, CE Clarke
Cochrane Database of Systematic Reviews, 2003
Targeting huntingtin expression in patients with Huntington’s disease
SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ...
New England Journal of Medicine 380 (24), 2307-2316, 2019
Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy
J Piedad, H Rickards, FMC Besag, AE Cavanna
CNS drugs 26 (4), 319-335, 2012
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiņas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
Treatment strategies for tics in Tourette syndrome
CM Eddy, HE Rickards, AE Cavanna
Therapeutic Advances in Neurological Disorders 4 (1), 25-45, 2011
The psychopathological spectrum of Gilles de la Tourette syndrome
AE Cavanna, H Rickards
Neuroscience & Biobehavioral Reviews 37 (6), 1008-1015, 2013
A pilot study using nabilone for symptomatic treatment in Huntington's disease
A Curtis, I Mitchell, S Patel, N Ives, H Rickards
Movement disorders: official journal of the Movement Disorder Society 24 (15 …, 2009
Time to end the distinction between mental and neurological illnesses
PD White, H Rickards, AZJ Zeman
Bmj 344, e3454, 2012
Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials
E Seiss, P Praamstra, C Hesse, H Rickards
Experimental Brain Research 148 (3), 308-319, 2003
Cannabinoids for Tourette's syndrome
A Curtis, CE Clarke, HE Rickards
Cochrane Database of Systematic Reviews, 2009
Systematic review of antidepressant therapies in Parkinson's disease☆
TH Chung, KHO Deane, S Ghazi-Noori, H Rickards, CE Clarke
Parkinsonism & related disorders 10 (2), 59-65, 2003
Impulse-control disorders in gilles de la tourette syndrome
A Wright, H Rickards, AE Cavanna
The Journal of neuropsychiatry and clinical neurosciences 24 (1), 16-27, 2012
The system can't perform the operation now. Try again later.
Articles 1–20